Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.13 USD | +2.52% |
|
+15.16% | +238.75% |
09:54am | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
Jul. 08 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+238.75% | 426M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.19% | 240B | |
+15.28% | 221B | |
+0.90% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing